• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测高级别浆液性卵巢癌铂敏感性的机器学习模型的开发

Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma.

作者信息

Hwangbo Suhyun, Kim Se Ik, Kim Ju-Hyun, Eoh Kyung Jin, Lee Chanhee, Kim Young Tae, Suh Dae-Shik, Park Taesung, Song Yong Sang

机构信息

Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul 08826, Korea.

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 03080, Korea.

出版信息

Cancers (Basel). 2021 Apr 14;13(8):1875. doi: 10.3390/cancers13081875.

DOI:10.3390/cancers13081875
PMID:33919797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8070756/
Abstract

To support the implementation of individualized disease management, we aimed to develop machine learning models predicting platinum sensitivity in patients with high-grade serous ovarian carcinoma (HGSOC). We reviewed the medical records of 1002 eligible patients. Patients' clinicopathologic characteristics, surgical findings, details of chemotherapy, treatment response, and survival outcomes were collected. Using the stepwise selection method, based on the area under the receiver operating characteristic curve (AUC) values, six variables associated with platinum sensitivity were selected: age, initial serum CA-125 levels, neoadjuvant chemotherapy, pelvic lymph node status, involvement of pelvic tissue other than the uterus and tubes, and involvement of the small bowel and mesentery. Based on these variables, predictive models were constructed using four machine learning algorithms, logistic regression (LR), random forest, support vector machine, and deep neural network; the model performance was evaluated with the five-fold cross-validation method. The LR-based model performed best at identifying platinum-resistant cases with an AUC of 0.741. Adding the FIGO stage and residual tumor size after debulking surgery did not improve model performance. Based on the six-variable LR model, we also developed a web-based nomogram. The presented models may be useful in clinical practice and research.

摘要

为支持个体化疾病管理的实施,我们旨在开发机器学习模型来预测高级别浆液性卵巢癌(HGSOC)患者的铂敏感性。我们回顾了1002例符合条件患者的病历。收集了患者的临床病理特征、手术发现、化疗细节、治疗反应和生存结果。采用逐步选择法,根据受试者工作特征曲线(AUC)值,选择了六个与铂敏感性相关的变量:年龄、初始血清CA-125水平、新辅助化疗、盆腔淋巴结状态、子宫和输卵管以外盆腔组织受累情况以及小肠和肠系膜受累情况。基于这些变量,使用四种机器学习算法构建预测模型,即逻辑回归(LR)、随机森林、支持向量机和深度神经网络;采用五折交叉验证法评估模型性能。基于LR的模型在识别铂耐药病例方面表现最佳,AUC为0.741。加入国际妇产科联盟(FIGO)分期和减瘤手术后的残留肿瘤大小并没有提高模型性能。基于六变量LR模型,我们还开发了一个基于网络的列线图。所提出的模型可能在临床实践和研究中有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/34edaccd213a/cancers-13-01875-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/d2f5592f5ea6/cancers-13-01875-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/9a2f997e563c/cancers-13-01875-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/911faeecc3d9/cancers-13-01875-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/34edaccd213a/cancers-13-01875-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/d2f5592f5ea6/cancers-13-01875-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/9a2f997e563c/cancers-13-01875-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/911faeecc3d9/cancers-13-01875-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4373/8070756/34edaccd213a/cancers-13-01875-g004.jpg

相似文献

1
Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma.用于预测高级别浆液性卵巢癌铂敏感性的机器学习模型的开发
Cancers (Basel). 2021 Apr 14;13(8):1875. doi: 10.3390/cancers13081875.
2
Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images.基于组织病理学图像深度学习分析的卵巢癌治疗反应预测
Cancers (Basel). 2023 Aug 10;15(16):4044. doi: 10.3390/cancers15164044.
3
Development of Web-Based Nomograms to Predict Treatment Response and Prognosis of Epithelial Ovarian Cancer.基于网络的列线图预测上皮性卵巢癌治疗反应和预后的研究进展。
Cancer Res Treat. 2019 Jul;51(3):1144-1155. doi: 10.4143/crt.2018.508. Epub 2018 Nov 20.
4
Feature Selection is Critical for 2-Year Prognosis in Advanced Stage High Grade Serous Ovarian Cancer by Using Machine Learning.使用机器学习对晚期高级别浆液性卵巢癌进行 2 年预后的特征选择至关重要。
Cancer Control. 2021 Jan-Dec;28:10732748211044678. doi: 10.1177/10732748211044678.
5
Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status.建立一种用于高级别浆液性卵巢癌患者的初始铂耐药预测指标,无论其同源重组缺陷状态如何。
Front Oncol. 2022 Mar 18;12:847085. doi: 10.3389/fonc.2022.847085. eCollection 2022.
6
Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma.开发和验证一种机器学习模型,以预测肾癌淋巴结转移的风险。
Front Endocrinol (Lausanne). 2022 Nov 18;13:1054358. doi: 10.3389/fendo.2022.1054358. eCollection 2022.
7
Can Machine-learning Algorithms Predict Early Revision TKA in the Danish Knee Arthroplasty Registry?机器学习算法能否预测丹麦膝关节置换登记处的早期翻修 TKA?
Clin Orthop Relat Res. 2020 Sep;478(9):2088-2101. doi: 10.1097/CORR.0000000000001343.
8
Machine Learning Predicts Lymph Node Metastasis in Early-Stage Oral Tongue Squamous Cell Carcinoma.机器学习预测早期口腔舌鳞状细胞癌的淋巴结转移
J Oral Maxillofac Surg. 2020 Dec;78(12):2208-2218. doi: 10.1016/j.joms.2020.06.015. Epub 2020 Jun 13.
9
Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian Cancer: Systematic Review and Meta-Analysis.机器学习对卵巢癌铂类化疗反应的预测价值:系统评价和荟萃分析。
J Med Internet Res. 2024 Jan 22;26:e48527. doi: 10.2196/48527.
10
How platinum-induced nephrotoxicity occurs? Machine learning prediction in non-small cell lung cancer patients.铂类诱导的肾毒性是如何发生的?非小细胞肺癌患者的机器学习预测。
Comput Methods Programs Biomed. 2022 Jun;221:106839. doi: 10.1016/j.cmpb.2022.106839. Epub 2022 Apr 26.

引用本文的文献

1
Proteomic alterations in ovarian cancer-Predicting residual disease status using artificial intelligence and SHAP-based biomarker interpretation.卵巢癌中的蛋白质组学改变——利用人工智能和基于SHAP的生物标志物解释预测残留疾病状态
Front Med (Lausanne). 2025 Jul 23;12:1562558. doi: 10.3389/fmed.2025.1562558. eCollection 2025.
2
Predicting the prognosis of radical gastrectomy for patients with locally advanced gastric cancer after neoadjuvant chemotherapy using machine learning technology: a multicenter study in China.利用机器学习技术预测新辅助化疗后局部晚期胃癌患者根治性胃切除术的预后:一项中国多中心研究
Surg Endosc. 2025 Jul 9. doi: 10.1007/s00464-025-11946-4.
3

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning.胰腺恶性导管内乳头状黏液性肿瘤的风险预测:逻辑回归与机器学习。
Sci Rep. 2020 Nov 18;10(1):20140. doi: 10.1038/s41598-020-76974-7.
3
Neoadjuvant chemotherapy-related platinum resistance in ovarian cancer.
CT-based radiomics model to predict platinum sensitivity in epithelial ovarian carcinoma: a multicentre study.
基于CT的放射组学模型预测上皮性卵巢癌铂敏感性:一项多中心研究。
Cancer Imaging. 2025 Jul 3;25(1):85. doi: 10.1186/s40644-025-00906-9.
4
Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges.肿瘤耐药性中新兴的人工智能驱动的精准疗法:最新进展、机遇与挑战
Mol Cancer. 2025 Apr 23;24(1):123. doi: 10.1186/s12943-025-02321-x.
5
Enhancing Personalized Chemotherapy for Ovarian Cancer: Integrating Gene Expression Data with Machine Learning.增强卵巢癌的个性化化疗:将基因表达数据与机器学习相结合。
Asian Pac J Cancer Prev. 2025 Mar 1;26(3):959-967. doi: 10.31557/APJCP.2025.26.3.959.
6
AI-Derived Blood Biomarkers for Ovarian Cancer Diagnosis: Systematic Review and Meta-Analysis.用于卵巢癌诊断的人工智能衍生血液生物标志物:系统评价与荟萃分析
J Med Internet Res. 2025 Mar 24;27:e67922. doi: 10.2196/67922.
7
Tailored chemotherapy: Innovative deep-learning model customizing chemotherapy for high-grade serous ovarian carcinoma.精准化疗:用于高级别浆液性卵巢癌的创新深度学习模型定制化疗方案
Clin Transl Med. 2024 Sep;14(9):e1774. doi: 10.1002/ctm2.1774.
8
Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian Cancer: Systematic Review and Meta-Analysis.机器学习对卵巢癌铂类化疗反应的预测价值:系统评价和荟萃分析。
J Med Internet Res. 2024 Jan 22;26:e48527. doi: 10.2196/48527.
9
Modern Subtype Classification and Outlier Detection Using the Attention Embedder to Transform Ovarian Cancer Diagnosis.利用注意力嵌入对卵巢癌诊断进行转换,实现现代亚型分类和异常值检测。
Tomography. 2024 Jan 15;10(1):105-132. doi: 10.3390/tomography10010010.
10
Development of prediction model to estimate future risk of ovarian lesions: A multi-center retrospective study.卵巢病变未来风险预测模型的开发:一项多中心回顾性研究。
Prev Med Rep. 2023 Jun 23;35:102296. doi: 10.1016/j.pmedr.2023.102296. eCollection 2023 Oct.
卵巢癌新辅助化疗相关铂耐药。
Drug Discov Today. 2020 Jul;25(7):1232-1238. doi: 10.1016/j.drudis.2020.04.015. Epub 2020 Apr 29.
4
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
5
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.奥拉帕利联合贝伐珠单抗作为卵巢癌一线维持治疗。
N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361.
6
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.尼拉帕利治疗新诊断的晚期卵巢癌患者。
N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28.
7
Ovarian cancer in the world: epidemiology and risk factors.全球卵巢癌:流行病学与风险因素
Int J Womens Health. 2019 Apr 30;11:287-299. doi: 10.2147/IJWH.S197604. eCollection 2019.
8
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.ESMO-ESGO 共识会议关于卵巢癌的建议:病理学和分子生物学,早期和晚期,交界性肿瘤和复发性疾病†。
Ann Oncol. 2019 May 1;30(5):672-705. doi: 10.1093/annonc/mdz062.
9
Developing prediction models for clinical use using logistic regression: an overview.使用逻辑回归开发临床应用的预测模型:综述
J Thorac Dis. 2019 Mar;11(Suppl 4):S574-S584. doi: 10.21037/jtd.2019.01.25.
10
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models.系统评价显示,机器学习在临床预测模型中并未优于逻辑回归。
J Clin Epidemiol. 2019 Jun;110:12-22. doi: 10.1016/j.jclinepi.2019.02.004. Epub 2019 Feb 11.